A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

Keratoconjunctivitis sicca (KCS) is a multifactorial disease characterized by tear hyperosmolarity, inflammation, and ocular surface damage. Cyclosporine A (CsA) is used as an effective disease-modifying agent to improve the signs and symptoms of KCS by reducing inflammation, which interferes with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerkins, Gary W, Pattar, Guruprasad R, Kannarr, Shane R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039096/
https://www.ncbi.nlm.nih.gov/pubmed/32109984
http://dx.doi.org/10.2147/OPTH.S228070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039096/
https://www.ncbi.nlm.nih.gov/pubmed/32109984
http://dx.doi.org/10.2147/OPTH.S228070

Ejemplares similares